ERBB2 and adenocarcinoma: Of 8 cases identified initially for this study (Cases 2 and 4–9 in Table 1), one HER2/neu-amplified, androgen receptor-negative high-grade adenocarcinoma was excluded due to lacking detailed clinical data and imaging to rule out a salivary gland tumor or other primary.